Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety Survey of Immunosuppressive Therapy in Living-Donor Liver Transplantation
jRCT1050210062Active, not recruiting
- Sponsor
- Juntendo University
- Start
- Mar 2022
- Countries
- 1
01
Overview
Open-label, single-arm trial in hepatic disease, sponsored by Juntendo University. Primary endpoints: Serious adverse events, Serious side effects and 1 more. Started Mar 2022; status: active, not recruiting.
02
Conditions
hepatic disease
Beyond the preview
Go deeper on jRCT1050210062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1050210062.